Decitabine Intravenous and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Decitabine Intravenous and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: decitabine
Brand name: Dacogen
Synonyms: Decitabine
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Decitabine Intravenous-Insulin glargine, recombinant Subcutaneous
- Decitabine Intravenous-Insulin glulisine
- Decitabine Intravenous-Insulin Glulisine (Cartridges and Pens)
- Decitabine Intravenous-Insulin Glulisine (Vials)
- Decitabine Intravenous-Insulin glulisine Subcutaneous
- Decitabine Intravenous-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Declomycin
- Insulin glargine and lixisenatide Subcutaneous-Decon-A
- Insulin glargine and lixisenatide Subcutaneous-Deconamine (Chlorpheniramine and Pseudoephedrine Liquid)
- Insulin glargine and lixisenatide Subcutaneous-Deconamine (Chlorpheniramine and Pseudoephedrine Tablets)
- Insulin glargine and lixisenatide Subcutaneous-Deconex
- Insulin glargine and lixisenatide Subcutaneous-Deconex DMX